Načítá se...

Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients

Cross-linking of α2-plasmin inhibitor (α2-PI) to fibrin by activated factor XIII (FXIIIa) is essential for the inhibition of fibrinolysis. Little is known about the factors modifying α2-PI incorporation into the fibrin clot and whether the extent of incorporation has clinical consequences. Herein we...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Biomolecules
Hlavní autoři:	Bagoly, Zsuzsa, Baráth, Barbara, Orbán-Kálmándi, Rita, Szegedi, István, Bogáti, Réka, Sarkady, Ferenc, Csiba, László, Katona, Éva
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI 2021
Témata:	Article
On-line přístup:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7996613/ https://ncbi.nlm.nih.gov/pubmed/33669007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom11030347
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo otaguje tento záznam!

Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients

Podobné jednotky